Curis Inc (NASDAQ:CRIS)
| 3.98 Data as of 1:37pm ET |  -0.14 / -3.40%Today’s Change | 2.66 Today|||52-Week Range 5.51 | +16.03% Year-to-Date |
Latest CRIS News | Press Releases
No recent news for Curis Inc.
Today’s Trading
| Previous close | 4.12 |
| Today’s open | 4.09 |
| Day’s range | 3.94 - 4.10 |
| Volume | 529,953 |
| Average volume (3 months) | 566,468 |
| Market cap | $331.8M |
| Dividend yield | -- |
Data as of 1:37pm ET, 05/20/2013
Growth & Valuation
| Earnings growth (last year) | -61.54% |
| Earnings growth (this year) | -3.57% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +14.97% |
| P/E ratio | NM |
| Price/Sales | 15.98 |
| Price/Book | 9.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVAXNovavax Inc | -0.05 | -2.74% |
| OSIROsiris Therapeutics ... | -0.36 | -3.19% |
| BTXBioTime Inc | -0.14 | -3.40% |
| OVASOvaScience Inc | +0.18 | +1.47% |
Data as of 1:52pm ET, 05/20/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $17.0M |
| Annual profit (last year) | -$16.4M |
| Net profit margin | -96.73% |
Profile
Sector Health Technology |
Industry Biotechnology |
President & Chief Operating Officer Ali Fattaey, PhD |
Chief Executive Officer & Director Daniel R. Passeri |
Corporate headquarters Lexington, Massachusetts |
Forecasts
